About the Report
The rising demand for oral clinical supplements is attributable to higher focus on maintaining a strong immunity. Following the outbreak of COVID-19 the demand in the oral clinical nutrition supplement market is poised to surge. Its applications in tackling the issue of malnutrition will aid the overall growth of the oral clinical nutrition supplement market.
Several oral clinical nutrition supplement manufacturers are introducing new flavors in order to attract more consumer base. This will remain one of the key factors spurring growth in the market.
In the latest edition of the report on the oral clinical nutrition supplement market, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights into key factors impacting the overall growth trajectory. The report tracks the global sales of oral clinical nutrition supplements in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the nutrition industry in general, and oral clinical nutrition supplement in particular.
How Does the Historical and Future Outlook of Oral Clinical Nutrition Supplement Market Match Up?
The Food and Drug Administration (FDA) has narrowly restricted illegal claims on diseases and health maintenance provided by the oral clinical nutrition supplement manufacturers on their products. Manufacturers who want to sell their oral clinical nutrition supplements with disease claims they must get it approved by FDA.
According to FMI’s analysis, oral clinical nutrition supplement sales has grown at CAGR more than 4.0% between 2016 and 2020. Rising interest of consumers in the oral clinical nutrition supplements is providing impetus to growth registered.
This also has been encouraging manufacturers to participate in research and development (R&D) activities. Some scientists are investigating whether increasing the quality of certain nutrients, such as vitamin C and vitamin E, with food additives such as probiotics or beyond the Prescribed Dietary Allowances (RDA), could improve bone health, especially in the elders.
This will also help the market in gaining traction. FMI projects that global oral clinical nutrition supplement to grow at CAGR around 6.0% through 2031.
Will Malnutrition Continue Spurring Oral Nutrition Supplements Sales?
An article, titled “Ready to use Therapeutic Food [RUTF] formulation and packaging for malnutrition: an Overview” highlighted how nutrition supplements are helping to tackle the issue of malnutrition.
Malnutrition is a universal challenge faced by several people around the world. Less than 45% of patients classified as malnourished receive adequate medical intervention around the globe. Malnutrition leads consumers to several consequences such as apathy, reduced muscle strength, impaired immune response, inactivity, impaired wound healing and fatigue, depression, and self-neglect which is leading consumers to poor quality of life.
Therefore, proper nutritional treatment planning has now become a crucial to fight against malnutrition and such nutritional assistance can be offered by an oral nutritional supplement. In a broad variety of patient groups, oral dietary supplements have demonstrated practical, nutritional, clinical and economic advantages, both in community areas and in hospitals.
Treatment of patients with high protein oral nutritional supplements has shown that total readmissions have been decreased by 30%, which has resulted in a rise in demand for oral nutritional supplements. Moreover, increasing evidence of effectiveness of oral clinical nutrition supplements in fight against malnutrition is expected to result in the increase demand for oral nutrition supplements over the forecast period.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Oral Clinical Nutrition Supplement Launch in Variety of Flavors and Forms
Oral nutritional supplements are usually prescribed to patients suffering from any chronic illness or malnutrition in order to improve their health conditions. It has been found that patients appear to lose interest in eating typical food products during some medical condition when they suffer a lack of taste.
In order to tackle this situation oral clinical nutrition supplement manufacturers are launching products in several forms and flavour. Innovative flavor and forms had significant impact on the consumers, primarily the millennial generation as they are very curious to try out new things.
This is a key trend influencing product launches over the last few years. For instance, in 2019 PRO-DIPTM launched oral nutrition supplements, in what it calls a revolutionary pouch. Originally intended to be a smokeless tobacco, PRO-DIP packed a burst of vitamins and natural energy supplements in small and semi-permeable sachets.
How has COVID-19 Impacted Oral Clinical Nutrition Supplement Sales?
The unprecedented outbreak of COVID-19 and its correlation with the immunity system of the consumers are affecting positively the oral clinical nutrition supplement market. Amid the ongoing crisis, consumers around the globe have become more concerned about personal health and immunity system.
In order to achieve this, consumers are opting for products that will help them to build and maintain strong immunity system. Besides this, their application in treatments administered to overcome nutritional deficiencies and in the management of disease-related malnutrition (DRM) will keep the demand high through the forecast period.
Why is Demand for Oral Clinical Nutrition High in U.S.?
The U.S. is one of the leading markets for oral clinical nutrition supplements. One of the key factor behind the growth of demand for oral clinical nutrition supplements is the increasing number of consumers having immunity deficiency.
According to WebMD, nearly 3% of adults in the U.S. have weakened immunity. The prevalence of immunosuppression is rising in the country. This reflects higher risk for autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and lupus.
Against this backdrop, the sales oral clinical nutrition is expected to remain considerably high. With the demand for non-invasive treatment methods rising, the U.S. is expected to remain a key market within North America.
It is expected to account for more than 25% of global sales of oral clinical nutrition supplements in year 2021 and remain dominant through the forecast period.
How big is opportunity in China?
China is one of the primary pockets for oral clinical nutrition supplements sales. It is expected to account for around 20% market share of global oral clinical supplements market.
The large patient population base coupled with an increase in incidences of chronic diseases provides lucrative growth opportunities for Oral Clinical Nutrition Supplement companies to record high sales in these markets.
For example, the International Network for Cancer Treatment and Research stated that, the burden of cancer in developing regions such as Asia Pacific is increasing rapidly, particularly in countries such as India and China.
China also is one of the most populated countries in the world, having a large patient pool affected with various chronic diseases. This would, in turn, increase the demand for oral clinical nutrition supplements.
What Will Drive Oral Clinical Nutrition Supplement Sales in GCC Countries?
GCC countries are among the key markets in MEA for oral clinical nutrition supplements. GCC countries are responsible for more than 80% sales of oral clinical nutrition supplements in MEA and they are expected to grow at CAGR more than 2.0% in the forecast period.
Why is Brazil Leading Latin America Oral Clinical Nutrition Supplement Market?
Brazil is dominating the oral clinical nutrition supplement market in Latin America. It accounted for more than 40.0% sales of oral clinical nutrition supplements in the region and is expected to grow at a high positive CAGR over the forecast period.
The key factor rising sales in Brazil is the increasing focus on health and wellness. Thus, in order to boost the immunity system and also to maintain the digestive health these consumers are seeking toward oral clinical nutrition supplements.
What is Russia’s Contribution towards Europe Oral Clinical Nutrition Supplement Market?
Russia is one of the leading markets for oral clinical nutrition supplements in Europe. It accounted for more than 10% sales in the region and is expected to grow at CAGR of more than 4.5% over the forecast period.
The prevalence of malnutrition and various autoimmune diseases will continue supporting expansion in the country.
Why is Standard Oral Nutrition Supplement Formula Preferred More?
FMI estimates that in the product type segment standard formula oral clinical nutrition supplements are holding more than 60% of market share.
The standard formula is consumed for several types of diseases/indications while specialized formula is specially developed to treat a patient suffering from a particular disease or a specific condition. This has resulted in higher consumption of the standard formula.
Why is General Well-being Considered Leading Indication?
Oral nutrition supplements are often taken for general well-being, catapulting it as the leading segment within the market in terms of indication. General well-being is projected to remain dominant through the course of the forecast period. It is likely to account for nearly 20% of sales registered.
Increasing focus on maintaining good health and immune systems among consumers will seal dominance of this segment through the forecast period.
How is Market Gaining from Rising Demand for Geriatric Population?
Geriatric population has emerged as the leading end user of oral clinical nutrition. The geriatric population segment will account over 40% of sales through the forecast period.
Low immunity in aged people can trigger various health issues. This makes geriatric population, key end users of oral clinical nutrition supplements.
What Is The Future Of Liquid Form Oral Clinical Nutrition Supplements?
Liquid form oral clinical nutrition supplements currently account for dominant 40% of the market and is expected to remain the leading segment in terms of form through the forecast period. Increasing launch of oral clinical nutrition formula in liquid form will continue aiding growth in this segment.
Which is the Preferred Oral Clinical Nutrition Supplement Flavor?
Flavoured oral clinical nutrition supplements currently hold more than 70% market share. In the flavored segment, chocolate flavoured oral clinical nutrition supplements are highly sought-after.
Which is the Preferred Sales Channel for Oral Clinical Nutrition Supplement Market?
Prescription based channels are responsible for more than 90% of sales of oral clinical nutrition supplements around the world. Oral clinical nutrition supplements are often administered as per dosage prescribed by doctors. This is expected to aid expansion within the sales channel.
The key players are mainly focusing on strategies which will help them increase their market share and gain competitive advantage.
- In Apr 2018, Abbott has introduced Ensure Max which is a nutritional drink with high quality proteins and very low amount of sugar.
- In Feb 2019, Matok V’Kal launched its stamina boost up spray which contains no caffeine and only six calories
- In Apr 2019, PRO-DIP introduced its oral clinical nutritional supplement a revolutionary pouch which provides energy and nutrition in small, semi-permeable sachets.
Some of the leading companies operating in the non-dairy creamer market are:
- NUTRICIÓN MÉDICA SL
- Meiji Holdings Co., Ltd.
- Medtrition Inc.
- Baxter International Inc.
- B. Braun Melsungen AG.
- Fresenius Kabi AG
- Mead Johnson & Company, LLC
- Otsuka Holdings Co., Ltd.
- Abbott Laboratories
- Danone Nutricia
- Victus, Inc.
- Cambrooke Therapeutics, Inc.
- GlaxoSmithKline plc
- Nestlé S.A.
- Kate Farms, Inc.
- Perrigo Company plc
- Sichuan Kelun Pharmaceutical Co., Ltd.
- AYMES International Ltd.
- Pfizer Inc.
- Medifood GmbH
- Nature’s Bounty Inc.
- Pharmavite LLC.
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
Historical Data Available for
USD Million for value and Units for Volume
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa
Key Countries Covered
US, Canada, Brazil, Mexico, Argentina, EU5, BENELUX, NORDIC, Russia, Poland, China, India, Japan, Australia & New Zealand, ASEAN, GCC Countries, North Africa, South Africa, Rest of MEA.
Key Segments Covered
Product Type, Indication, Form, End User, Flavour, Sales Channel
Key Companies Profiled
Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Key Questions Answered in the Report
Which is the most lucrative market for oral clinical nutrition supplements?
US currently leads the global oral clinical nutrition market. US covers more than 80% of total sales in North America valued in 2021 and US is expected to show a significant growth and dominate the global oral clinical nutrition supplement market in the forecast period.
Which product type is leading the global oral clinical nutrition supplement market?
The standard formula product type is leading the global oral clinical nutrition supplement market with holding more than 60% of the global market share and it is expected to dominate the global oral clinical nutrition supplement market even in the forecasted period.
Which is the major indication for use of oral clinical nutrition supplement?
General Well-being is the major indication why consumers opt for oral clinical nutrition supplements. Around 20% of consumers opt for oral clinical nutrition supplements due to general well-being and it is expected to be the foremost indication even in the forecasted period.
Consumers majorly prefers oral clinical nutrition supplements in which form?
More than 40% of consumers prefers oral clinical nutrition supplements in liquid form and liquid form oral clinical nutrition supplements are expected to dominate the market in the forecasted period.
Who is the major consumer of oral clinical nutrition supplements?
Consumers from geriatric population are one of the major consumer of oral clinical nutrition supplements. More than 40% of consumers of oral clinical nutrition supplements are from the geriatric population as the huge number of population from geriatric population are having immunity deficiency.
Among the regular and flavoured which is the most preferred oral clinical nutrition supplements?
Among regular and flavoured, flavoured oral clinical nutrition supplements are the most preferred by the consumers which is holding more than 70% of market share. In flavoured chocolate flavoured oral clinical nutrition supplements are the most preferred by the consumers. Chocolate flavoured oral clinical nutrition supplements are holding more than 25% of market share in flavoured oral clinical nutrition supplements segment.
Which are some of the leading companies offering oral clinical nutrition supplements?
Some of the leading players in the oral clinical nutrition supplements industry are NUTRICIÓN MÉDICA SL, Meiji Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B. Braun Melsungen AG., Fresenius Kabi Ltd, Mead Johnson & Company, LLC, Otsuka Holdings Co., Ltd., Abbott Laboratories, Danone Nutricia, Victus, Inc., Cambrooke Therapeutics, Inc., and others.
Enquiry before Buying
Is this research conducted by Future Market Insights?
Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst
What research methodology is followed by FMI?
FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology
Who are the respondents for primary research?
FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.
What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Is a sample of this report available for evaluation?
Yes, you can request a sample and it will be sent to you through an email.
How can I buy this report?
FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.
Oral Clinical Nutrition Supplements Market by Category
- Standard Formula
- Specialized Formula
- General Well-being
- Renal Disorders
- Hepatic Disorders
- Oncology Nutrition
- IBD & GI Tract Disorders
- Neurological Disorders
- Respiratory Orders
- Mixed Berries
- Nut Flavours
- Modern Trade
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- North America
- The U.S.
- Latin America
- Rest of LATAM
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- North Africa
- South Africa
- Rest of MEA